deltatrials
Completed NCT00772733

A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) Treatment

Sponsor: AstraZeneca

Conditions COPD Chronic Diseases
Updated 7 times since 2017 Last updated: Feb 21, 2011 Started: Oct 31, 2008 Primary completion: Dec 31, 2010 Completion: Dec 31, 2010

Listed as NCT00772733, this observational or N/A phase trial focuses on COPD and Chronic Diseases and remains completed. Sponsored by AstraZeneca, it has been updated 7 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Jan 2021 — Jul 2024 [monthly]

    Completed

  5. Jun 2018 — Jan 2021 [monthly]

    Completed

▶ Show 2 earlier versions

  1. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NA → None

  2. Jan 2017 — Apr 2018 [monthly]

    Completed NA

    First recorded

Oct 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AstraZeneca
Data source: AstraZeneca

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aalborg, Denmark, Aarhus, Denmark, Bjerringbro, Denmark, Klarup, Denmark, Møldrup, Denmark, Skals, Denmark, Skive, Denmark, Spøttrup, Denmark, Stoholm, Denmark, Viborg, Denmark and 1 more location